2022 Q4 Form 20-F Financial Statement

#000121390023020144 Filed on March 15, 2023

View on sec.gov

Income Statement

Concept 2022 Q4 2022 2021 Q4
Revenue $81.60M $11.83M $129.8M
YoY Change -37.14% -98.38% -43.17%
Cost Of Revenue $69.41M $10.06M $85.50M
YoY Change -18.83% -97.92% -44.66%
Gross Profit $12.19M $1.768M $44.31M
YoY Change -72.48% -99.28% -40.04%
Gross Profit Margin 14.94% 14.94% 34.13%
Selling, General & Admin $4.971M $4.971M $72.68M
YoY Change -93.16% -99.16% -65.32%
% of Gross Profit 40.77% 281.17% 164.04%
Research & Development $7.673M
YoY Change -26.22%
% of Gross Profit 17.32%
Depreciation & Amortization $12.12M 12.53M cnies $16.82M
YoY Change -27.94% -66.93%
% of Gross Profit 99.4% 708.6% 37.96%
Operating Expenses $4.971M $4.971M $80.35M
YoY Change -93.81% -99.19% -63.48%
Operating Profit $7.223M $1.047M -$36.05M
YoY Change -120.04% -100.29% -75.33%
Interest Expense $1.327M $20.00K -$11.82M
YoY Change -111.22% -100.17% -74.07%
% of Operating Profit 18.37% 1.91%
Other Income/Expense, Net $28.00K $6.267M
YoY Change -99.67% -84.29%
Pretax Income $6.670M $967.0K -$64.75M
YoY Change -110.3% -100.24% -64.75%
Income Tax $0.00 -$23.46M
% Of Pretax Income 0.0%
Net Earnings $53.01M $5.637M -$47.57M
YoY Change -211.44% -101.47% -71.6%
Net Earnings / Revenue 64.97% 47.65% -36.65%
Basic Earnings Per Share $3.39
Diluted Earnings Per Share $3.88 $3.39 -$4.184M
COMMON SHARES
Basic Shares Outstanding 20.88M shares 13.66M shares
Diluted Shares Outstanding 13.66M shares

Balance Sheet

Concept 2022 Q4 2022 2021 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $333.0K $300.0K $168.4M
YoY Change -99.8% -99.82% 86.91%
Cash & Equivalents $48.00K $300.0K $168.4M
Short-Term Investments
Other Short-Term Assets $8.221M $35.20M $132.2M
YoY Change -93.78% -73.38% 103.09%
Inventory
Prepaid Expenses $3.237M
Receivables $8.902M $61.40M $81.86M
Other Receivables $0.00 $0.00 $7.265M
Total Short-Term Assets $14.06M $96.90M $389.7M
YoY Change -96.39% -75.14% 60.06%
LONG-TERM ASSETS
Property, Plant & Equipment $13.40M $92.40M $191.4M
YoY Change -93.0% -51.71% -59.24%
Goodwill $193.0M $193.0M
YoY Change 0.0%
Intangibles
YoY Change
Long-Term Investments $2.885M $19.90M $24.40M
YoY Change -88.18% -18.45% -0.8%
Other Assets $16.39M $0.00 $61.09M
YoY Change -73.17% -100.0% 5.14%
Total Long-Term Assets $16.29M $112.4M $495.6M
YoY Change -96.71% -77.32% -42.05%
TOTAL ASSETS
Total Short-Term Assets $14.06M $96.90M $389.7M
Total Long-Term Assets $16.29M $112.4M $495.6M
Total Assets $30.34M $209.3M $885.4M
YoY Change -96.57% -76.36% -19.42%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $3.455M $23.80M $16.16M
YoY Change -78.63% 47.24% -4.92%
Accrued Expenses $78.21M
YoY Change -68.05%
Deferred Revenue
YoY Change
Short-Term Debt $5.998M $6.000M $6.000M
YoY Change -0.03% 0.0% -95.52%
Long-Term Debt Due $337.9M
YoY Change -12.13%
Total Short-Term Liabilities $11.06M $76.30M $714.9M
YoY Change -98.45% -89.33% -39.04%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $0.00 $0.00 $129.5M
YoY Change -100.0% -100.0% -53.93%
Total Long-Term Liabilities $0.00 $129.5M
YoY Change -100.0% -53.93%
TOTAL LIABILITIES
Total Short-Term Liabilities $11.06M $76.30M $714.9M
Total Long-Term Liabilities $0.00 $129.5M
Total Liabilities $11.06M $76.30M $862.9M
YoY Change -98.72% -91.16% -41.6%
SHAREHOLDERS EQUITY
Retained Earnings -$183.8M -1.321B cnies
YoY Change -86.08%
Common Stock $63.00K 217.0K cnies
YoY Change -70.97%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $19.28M $133.0M $22.44M
YoY Change
Total Liabilities & Shareholders Equity $30.34M $209.3M $885.4M
YoY Change -96.57% -76.36% -19.42%

Cashflow Statement

Concept 2022 Q4 2022 2021 Q4
OPERATING ACTIVITIES
Net Income $53.01M $5.637M -$47.57M
YoY Change -211.44% -101.47% -71.6%
Depreciation, Depletion And Amortization $12.12M 12.53M cnies $16.82M
YoY Change -27.94% -66.93%
Cash From Operating Activities -$78.92M -$31.05M -$306.3M
YoY Change -74.23% -93.24%
INVESTING ACTIVITIES
Capital Expenditures -$2.263M $8.875M -$71.52M
YoY Change -96.84% -112.15%
Acquisitions
YoY Change
Other Investing Activities -$15.27M $44.97M -$88.00K
YoY Change 17248.86% 3961.88%
Cash From Investing Activities -$13.00M -$2.356M -$71.61M
YoY Change -81.84% -96.73%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $6.459M $744.4M
YoY Change -99.13%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 65.81M $7.752M 402.8M
YoY Change -83.66% -98.73%
NET CHANGE
Cash From Operating Activities -78.92M -$31.05M -306.3M
Cash From Investing Activities -13.00M -$2.356M -71.61M
Cash From Financing Activities 65.81M $7.752M 402.8M
Net Change In Cash -26.12M -$25.65M 24.85M
YoY Change -205.12% -133.41%
FREE CASH FLOW
Cash From Operating Activities -$78.92M -$31.05M -$306.3M
Capital Expenditures -$2.263M $8.875M -$71.52M
Free Cash Flow -$76.66M -$39.92M -$234.8M
YoY Change -67.35% -89.66%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022 dei Document Type
DocumentType
20-F
CY2022 dei Document Registration Statement
DocumentRegistrationStatement
false
CY2022 dei Document Annual Report
DocumentAnnualReport
true
CY2022 dei Document Period End Date
DocumentPeriodEndDate
2022-12-31
CY2022 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022 dei Document Transition Report
DocumentTransitionReport
false
CY2022 dei Document Shell Company Report
DocumentShellCompanyReport
false
CY2022 dei Entity File Number
EntityFileNumber
001-39258
CY2022 dei Entity Registrant Name
EntityRegistrantName
METEN HOLDING GROUP LTD.
CY2022 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
E9
CY2022 dei Entity Address Address Line1
EntityAddressAddressLine1
c/o 3rd Floor
CY2022 dei Entity Address Address Line2
EntityAddressAddressLine2
Tower ATagen Knowledge & Innovation Center
CY2022 dei Entity Address Address Line3
EntityAddressAddressLine3
2nd Shenyun West Road, Nanshan District
CY2022 dei Entity Address City Or Town
EntityAddressCityOrTown
Shenzhen
CY2022 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
518000
CY2022 dei Entity Address Country
EntityAddressCountry
CN
CY2022 dei Security12b Title
Security12bTitle
Ordinary shares, par value US$0.003 per share
CY2022 dei Trading Symbol
TradingSymbol
METX
CY2022 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2022Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
20880171 shares
CY2022 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2022 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2022 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2022 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2022 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2022 dei Entity Shell Company
EntityShellCompany
false
CY2022 dei Auditor Firm
AuditorFirmId
3487
CY2022 dei Auditor Name
AuditorName
Audit Alliance LLP
CY2022 dei Auditor Location
AuditorLocation
Singapore
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
168404000 cny
CY2022Q4 us-gaap Other Assets
OtherAssets
626000 cny
CY2022Q4 us-gaap Other Assets
OtherAssets
91000 usd
CY2021Q4 us-gaap Assets Of Disposal Group Including Discontinued Operation Current
AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
142199000 cny
CY2021Q4 us-gaap Assets Current
AssetsCurrent
389738000 cny
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
333000 cny
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
48000 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
61396000 cny
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
8902000 usd
CY2021Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
79135000 cny
CY2022Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
34582000 cny
CY2022Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
5015000 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
96937000 cny
CY2022Q4 us-gaap Assets Current
AssetsCurrent
14056000 usd
CY2021Q4 us-gaap Restricted Cash
RestrictedCash
8840000 cny
CY2022Q4 us-gaap Equity Method Investments
EquityMethodInvestments
19900000 cny
CY2022Q4 us-gaap Equity Method Investments
EquityMethodInvestments
2885000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
92443000 cny
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
13403000 usd
CY2021Q4 us-gaap Disposal Group Including Discontinued Operation Assets Noncurrent
DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent
486788000 cny
CY2021Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
495628000 cny
CY2022Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
112343000 cny
CY2022Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
16288000 usd
CY2021Q4 us-gaap Assets
Assets
885366000 cny
CY2022Q4 us-gaap Assets
Assets
209280000 cny
CY2022Q4 us-gaap Assets
Assets
30344000 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
23829000 cny
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
3455000 usd
CY2022Q4 us-gaap Other Short Term Borrowings
OtherShortTermBorrowings
5998000 cny
CY2022Q4 us-gaap Other Short Term Borrowings
OtherShortTermBorrowings
870000 usd
CY2021Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
30502000 cny
CY2022Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
46478000 cny
CY2022Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
6739000 usd
CY2021Q4 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Current
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
684349000 cny
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
714851000 cny
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
76305000 cny
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
11064000 usd
CY2021Q4 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Noncurrent
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent
133940000 cny
CY2021Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
133940000 cny
CY2021Q4 us-gaap Liabilities
Liabilities
848791000 cny
CY2022Q4 us-gaap Liabilities
Liabilities
76305000 cny
CY2022Q4 us-gaap Liabilities
Liabilities
11064000 usd
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
11371444 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
11371444 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
20880171 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
20880171 shares
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
63000 usd
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1342769000 cny
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1400076000 cny
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
202992000 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1320546000 cny
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1267533000 cny
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-183775000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
22440000 cny
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
132975000 cny
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
19280000 usd
CY2021Q4 us-gaap Minority Interest
MinorityInterest
14135000 cny
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
36575000 cny
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
132975000 cny
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
19280000 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
885366000 cny
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
209280000 cny
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
30344000 usd
CY2022 us-gaap Revenues
Revenues
81599000 cny
CY2022 us-gaap Revenues
Revenues
11831000 usd
CY2022 us-gaap Cost Of Revenue
CostOfRevenue
69405000 cny
CY2022 us-gaap Cost Of Revenue
CostOfRevenue
10063000 usd
CY2022 us-gaap Gross Profit
GrossProfit
12194000 cny
CY2022 us-gaap Gross Profit
GrossProfit
1768000 usd
CY2020 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8158000 cny
CY2021 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6762000 cny
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4971000 cny
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
721000 usd
CY2020 us-gaap Operating Income Loss
OperatingIncomeLoss
-8158000 cny
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
-6762000 cny
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
7223000 cny
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
1047000 usd
CY2022 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-1880000 cny
CY2022 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-273000 usd
CY2020 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
5000 cny
CY2021 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
34000 cny
CY2022 us-gaap Interest Expense
InterestExpense
141000 cny
CY2022 us-gaap Interest Expense
InterestExpense
20000 usd
CY2020 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-4134000 cny
CY2021 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-5374000 cny
CY2022 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
1191000 cny
CY2022 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
173000 usd
CY2022 us-gaap Noncontrolling Interest In Net Income Loss Other Noncontrolling Interests Redeemable
NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable
-83000 cny
CY2022 us-gaap Noncontrolling Interest In Net Income Loss Other Noncontrolling Interests Redeemable
NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable
-12000 usd
CY2020 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
495000 cny
CY2022 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
194000 cny
CY2022 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
28000 usd
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-11792000 cny
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-12102000 cny
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
6670000 cny
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
967000 usd
CY2020 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-11792000 cny
CY2021 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-12102000 cny
CY2022 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
6670000 cny
CY2022 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
967000 usd
CY2020 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-400991000 cny
CY2021 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-374195000 cny
CY2022 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-42520000 cny
CY2022 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-6165000 usd
CY2022 metx Gains On Disposal Of Subsidiaries
GainsOnDisposalOfSubsidiaries
74728000 cny
CY2022 metx Gains On Disposal Of Subsidiaries
GainsOnDisposalOfSubsidiaries
10835000 usd
CY2020 metx Net Incomeloss From Discontinued Operations Net Of Income Taxes
NetIncomelossFromDiscontinuedOperationsNetOfIncomeTaxes
-400991000 cny
CY2021 metx Net Incomeloss From Discontinued Operations Net Of Income Taxes
NetIncomelossFromDiscontinuedOperationsNetOfIncomeTaxes
-374195000 cny
CY2022 metx Net Incomeloss From Discontinued Operations Net Of Income Taxes
NetIncomelossFromDiscontinuedOperationsNetOfIncomeTaxes
32208000 cny
CY2022 metx Net Incomeloss From Discontinued Operations Net Of Income Taxes
NetIncomelossFromDiscontinuedOperationsNetOfIncomeTaxes
4670000 usd
CY2020 us-gaap Profit Loss
ProfitLoss
-412783000 cny
CY2021 us-gaap Profit Loss
ProfitLoss
-386297000 cny
CY2022 us-gaap Profit Loss
ProfitLoss
38878000 cny
CY2022 us-gaap Profit Loss
ProfitLoss
5637000 usd
CY2020 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Noncontrolling Interest
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToNoncontrollingInterest
-1798000 cny
CY2021 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Noncontrolling Interest
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToNoncontrollingInterest
-1998000 cny
CY2022 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Noncontrolling Interest
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToNoncontrollingInterest
-14135000 cny
CY2022 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Noncontrolling Interest
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToNoncontrollingInterest
-2049000 usd
CY2020 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-1798000 cny
CY2021 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-1998000 cny
CY2022 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-14135000 cny
CY2022 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-2049000 usd
CY2020 metx Net Loss Available To Shareholders Of The Company
NetLossAvailableToShareholdersOfTheCompany
410985000 cny
CY2021 metx Net Loss Available To Shareholders Of The Company
NetLossAvailableToShareholdersOfTheCompany
384299000 cny
CY2022 metx Net Loss Available To Shareholders Of The Company
NetLossAvailableToShareholdersOfTheCompany
-53013000 cny
CY2022 metx Net Loss Available To Shareholders Of The Company
NetLossAvailableToShareholdersOfTheCompany
-7686000 usd
CY2020 us-gaap Profit Loss
ProfitLoss
-412783000 cny
CY2021 us-gaap Profit Loss
ProfitLoss
-386297000 cny
CY2022 us-gaap Profit Loss
ProfitLoss
38878000 cny
CY2022 us-gaap Profit Loss
ProfitLoss
5637000 usd
CY2020 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-412783000 cny
CY2021 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-386297000 cny
CY2022 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
38878000 cny
CY2022 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
5637000 usd
CY2021 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-26.63
CY2022 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.49
CY2022 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.07
CY2020 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
-6454.62
CY2021 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
-818.92
CY2022 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
3.39
CY2020 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
495000 cny
CY2020 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
3001000 cny
CY2021 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
318000 cny
CY2022 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
26666000 cny
CY2022 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
3866000 usd
CY2022 metx Impairment Losses On Cryptocurrency Assets
ImpairmentLossesOnCryptocurrencyAssets
22000 cny
CY2022 metx Impairment Losses On Cryptocurrency Assets
ImpairmentLossesOnCryptocurrencyAssets
3000 usd
CY2022 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0.49
CY2020 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-161.19
CY2021 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-30.15
CY2022 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.49
CY2022 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.07
CY2020 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
-5456.6
CY2021 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
-927.4
CY2022 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
3.39
CY2022 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
0.49
CY2020 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
61846 shares
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
454495 shares
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13655571 shares
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13655571 shares
CY2020 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
73158 shares
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
401335 shares
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
13655571 shares
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
13655571 shares
CY2019Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-242939000 cny
CY2020 us-gaap Profit Loss
ProfitLoss
-412783000 cny
CY2020 metx Recapitalization
Recapitalization
199806000 cny
CY2020 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
41118000 cny
CY2020 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
52256000 cny
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-362542000 cny
CY2021 us-gaap Profit Loss
ProfitLoss
-386297000 cny
CY2021 metx Recapitalization
Recapitalization
762080000 cny
CY2021 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
23334000 cny
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
36575000 cny
CY2022 us-gaap Profit Loss
ProfitLoss
38878000 cny
CY2022 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
5854000 cny
CY2022 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
51668000 cny
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
132975000 cny
CY2020 us-gaap Profit Loss
ProfitLoss
-412783000 cny
CY2021 us-gaap Profit Loss
ProfitLoss
-386297000 cny
CY2022 us-gaap Profit Loss
ProfitLoss
38878000 cny
CY2022 us-gaap Profit Loss
ProfitLoss
5637000 usd
CY2020 us-gaap Depreciation And Amortization
DepreciationAndAmortization
55950000 cny
CY2021 us-gaap Depreciation And Amortization
DepreciationAndAmortization
37881000 cny
CY2022 us-gaap Depreciation And Amortization
DepreciationAndAmortization
28802000 cny
CY2022 us-gaap Depreciation And Amortization
DepreciationAndAmortization
4176000 usd
CY2020 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
125468000 cny
CY2021 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
72471000 cny
CY2022 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
9281000 cny
CY2022 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
1346000 usd
CY2022 metx Realized Gain On Exchange Of Digital Assets
RealizedGainOnExchangeOfDigitalAssets
1880000 cny
CY2022 metx Realized Gain On Exchange Of Digital Assets
RealizedGainOnExchangeOfDigitalAssets
273000 usd
CY2020 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
27591000 cny
CY2021 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
81605000 cny
CY2020 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
23944000 cny
CY2021 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
7240000 cny
CY2022 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
11395000 cny
CY2022 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1652000 usd
CY2020 us-gaap Equity Method Investment Realized Gain Loss On Disposal
EquityMethodInvestmentRealizedGainLossOnDisposal
-1532000 cny
CY2021 us-gaap Equity Method Investment Realized Gain Loss On Disposal
EquityMethodInvestmentRealizedGainLossOnDisposal
-149000 cny
CY2022 us-gaap Equity Method Investment Realized Gain Loss On Disposal
EquityMethodInvestmentRealizedGainLossOnDisposal
3534000 cny
CY2022 us-gaap Equity Method Investment Realized Gain Loss On Disposal
EquityMethodInvestmentRealizedGainLossOnDisposal
512000 usd
CY2020 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-2786000 cny
CY2021 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-20650000 cny
CY2022 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
406000 cny
CY2022 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
59000 usd
CY2020 metx Loss On Disposal And Closure Of Subsidiaries And Branches
LossOnDisposalAndClosureOfSubsidiariesAndBranches
31884000 cny
CY2021 metx Loss On Disposal And Closure Of Subsidiaries And Branches
LossOnDisposalAndClosureOfSubsidiariesAndBranches
37829000 cny
CY2022 metx Loss On Disposal And Closure Of Subsidiaries And Branches
LossOnDisposalAndClosureOfSubsidiariesAndBranches
18199000 cny
CY2022 metx Loss On Disposal And Closure Of Subsidiaries And Branches
LossOnDisposalAndClosureOfSubsidiariesAndBranches
2639000 usd
CY2020 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
41118000 cny
CY2021 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
2404000 cny
CY2020 us-gaap Share Based Compensation
ShareBasedCompensation
52256000 cny
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
23334000 cny
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
5854000 cny
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
849000 usd
CY2022 metx Gains On Disposal Of Subsidiaries And Vi Es
GainsOnDisposalOfSubsidiariesAndVIEs
74728000 cny
CY2022 metx Gains On Disposal Of Subsidiaries And Vi Es
GainsOnDisposalOfSubsidiariesAndVIEs
10835000 usd
CY2020 us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
-1630000 cny
CY2021 us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
-871000 cny
CY2022 us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
-1478000 cny
CY2022 us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
-214000 usd
CY2020 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
22125000 cny
CY2021 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
24576000 cny
CY2022 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
71216000 cny
CY2022 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
10325000 usd
CY2020 metx Increasedecrease In Other Contract Costs
IncreasedecreaseInOtherContractCosts
7761000 cny
CY2021 metx Increasedecrease In Other Contract Costs
IncreasedecreaseInOtherContractCosts
13051000 cny
CY2022 metx Increasedecrease In Other Contract Costs
IncreasedecreaseInOtherContractCosts
18781000 cny
CY2022 metx Increasedecrease In Other Contract Costs
IncreasedecreaseInOtherContractCosts
2723000 usd
CY2020 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-5849000 cny
CY2021 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
24225000 cny
CY2022 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
6684000 cny
CY2022 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
969000 usd
CY2020 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-21681000 cny
CY2021 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-14500000 cny
CY2022 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-10204000 cny
CY2022 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-1479000 usd
CY2022 metx Increasedecreasecryptocurrencyassets
Increasedecreasecryptocurrencyassets
2528000 cny
CY2022 metx Increasedecreasecryptocurrencyassets
Increasedecreasecryptocurrencyassets
367000 usd
CY2020 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1274000 cny
CY2021 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-849000 cny
CY2022 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
22684000 cny
CY2022 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
3289000 usd
CY2020 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-79954000 cny
CY2021 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-140309000 cny
CY2022 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-86996000 cny
CY2022 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-12613000 usd
CY2020 metx Increasedecrease In Salary And Welfare Payable
IncreasedecreaseInSalaryAndWelfarePayable
-6530000 cny
CY2021 metx Increasedecrease In Salary And Welfare Payable
IncreasedecreaseInSalaryAndWelfarePayable
-24880000 cny
CY2022 metx Increasedecrease In Salary And Welfare Payable
IncreasedecreaseInSalaryAndWelfarePayable
-17996000 cny
CY2022 metx Increasedecrease In Salary And Welfare Payable
IncreasedecreaseInSalaryAndWelfarePayable
-2609000 usd
CY2020 metx Increasedecrease In Financial Liabilities From Contracts With Customers
IncreasedecreaseInFinancialLiabilitiesFromContractsWithCustomers
-105534000 cny
CY2021 metx Increasedecrease In Financial Liabilities From Contracts With Customers
IncreasedecreaseInFinancialLiabilitiesFromContractsWithCustomers
-46629000 cny
CY2022 metx Increasedecrease In Financial Liabilities From Contracts With Customers
IncreasedecreaseInFinancialLiabilitiesFromContractsWithCustomers
-70136000 cny
CY2022 metx Increasedecrease In Financial Liabilities From Contracts With Customers
IncreasedecreaseInFinancialLiabilitiesFromContractsWithCustomers
-10169000 usd
CY2020 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
-7031000 cny
CY2021 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
-11027000 cny
CY2022 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
-12751000 cny
CY2022 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
-1849000 usd
CY2020 us-gaap Increase Decrease In Prepaid Taxes
IncreaseDecreaseInPrepaidTaxes
1315000 cny
CY2021 us-gaap Increase Decrease In Prepaid Taxes
IncreaseDecreaseInPrepaidTaxes
19000 cny
CY2022 us-gaap Increase Decrease In Prepaid Taxes
IncreaseDecreaseInPrepaidTaxes
-236000 cny
CY2022 us-gaap Increase Decrease In Prepaid Taxes
IncreaseDecreaseInPrepaidTaxes
-34000 usd
CY2020 metx Decrease In Operating Lease Liabilities
DecreaseInOperatingLeaseLiabilities
107007000 cny
CY2021 metx Decrease In Operating Lease Liabilities
DecreaseInOperatingLeaseLiabilities
71206000 cny
CY2022 metx Decrease In Operating Lease Liabilities
DecreaseInOperatingLeaseLiabilities
9060000 cny
CY2022 metx Decrease In Operating Lease Liabilities
DecreaseInOperatingLeaseLiabilities
1314000 usd
CY2020 us-gaap Increase Decrease In Accrued Taxes Payable
IncreaseDecreaseInAccruedTaxesPayable
7405000 cny
CY2021 us-gaap Increase Decrease In Accrued Taxes Payable
IncreaseDecreaseInAccruedTaxesPayable
347000 cny
CY2022 us-gaap Increase Decrease In Accrued Taxes Payable
IncreaseDecreaseInAccruedTaxesPayable
68000 cny
CY2022 us-gaap Increase Decrease In Accrued Taxes Payable
IncreaseDecreaseInAccruedTaxesPayable
9000 usd
CY2020 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-343218000 cny
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-459303000 cny
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-214127000 cny
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-31046000 usd
CY2020 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
25652000 cny
CY2021 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
73050000 cny
CY2022 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
61212000 cny
CY2022 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
8875000 usd
CY2022 metx Disposal Of Subsidiaries And Vi Es
DisposalOfSubsidiariesAndVIEs
17476000 cny
CY2022 metx Disposal Of Subsidiaries And Vi Es
DisposalOfSubsidiariesAndVIEs
2534000 usd
CY2022 us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
12407000 cny
CY2022 us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
1799000 usd
CY2020 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
22749000 cny
CY2021 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
438000 cny
CY2022 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
73143000 cny
CY2022 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
10605000 usd
CY2020 metx Advances From Related Parties
AdvancesFromRelatedParties
-10219000 cny
CY2021 metx Advances From Related Parties
AdvancesFromRelatedParties
-44198000 cny
CY2022 metx Advances From Related Parties
AdvancesFromRelatedParties
-1336000 cny
CY2022 metx Advances From Related Parties
AdvancesFromRelatedParties
-194000 usd
CY2020 us-gaap Repayment Of Notes Receivable From Related Parties
RepaymentOfNotesReceivableFromRelatedParties
11947000 cny
CY2021 us-gaap Repayment Of Notes Receivable From Related Parties
RepaymentOfNotesReceivableFromRelatedParties
44867000 cny
CY2022 us-gaap Repayment Of Notes Receivable From Related Parties
RepaymentOfNotesReceivableFromRelatedParties
3041000 cny
CY2022 us-gaap Repayment Of Notes Receivable From Related Parties
RepaymentOfNotesReceivableFromRelatedParties
441000 usd
CY2020 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
42001000 cny
CY2020 metx Proceeds From Maturities Of Shortterm Investment
ProceedsFromMaturitiesOfShorttermInvestment
42496000 cny
CY2020 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-680000 cny
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-71943000 cny
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-16247000 cny
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2356000 usd
CY2020 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
63664000 cny
CY2021 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
97478000 cny
CY2022 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
28021000 cny
CY2022 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
4063000 usd
CY2020 us-gaap Payments Of Merger Related Costs Financing Activities
PaymentsOfMergerRelatedCostsFinancingActivities
14323000 cny
CY2021 us-gaap Payments Of Merger Related Costs Financing Activities
PaymentsOfMergerRelatedCostsFinancingActivities
105912000 cny
CY2022 us-gaap Payments Of Merger Related Costs Financing Activities
PaymentsOfMergerRelatedCostsFinancingActivities
19104000 cny
CY2022 us-gaap Payments Of Merger Related Costs Financing Activities
PaymentsOfMergerRelatedCostsFinancingActivities
2770000 usd
CY2020 us-gaap Proceeds From Bank Debt
ProceedsFromBankDebt
185000000 cny
CY2021 us-gaap Proceeds From Bank Debt
ProceedsFromBankDebt
27000000 cny
CY2022 us-gaap Proceeds From Bank Debt
ProceedsFromBankDebt
7177000 cny
CY2022 us-gaap Proceeds From Bank Debt
ProceedsFromBankDebt
1041000 usd
CY2020 us-gaap Repayments Of Bank Debt
RepaymentsOfBankDebt
143100000 cny
CY2021 us-gaap Repayments Of Bank Debt
RepaymentsOfBankDebt
154900000 cny
CY2022 us-gaap Repayments Of Bank Debt
RepaymentsOfBankDebt
7179000 cny
CY2022 us-gaap Repayments Of Bank Debt
RepaymentsOfBankDebt
1041000 usd
CY2020 metx Proceeds From Recapitalization
ProceedsFromRecapitalization
216172000 cny
CY2021 metx Proceeds From Recapitalization
ProceedsFromRecapitalization
744351000 cny
CY2022 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
44548000 cny
CY2022 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
6459000 usd
CY2020 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
14773000 cny
CY2020 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
292640000 cny
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
608017000 cny
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
53463000 cny
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
7752000 usd
CY2020 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-51258000 cny
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
76771000 cny
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-176911000 cny
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-25650000 usd
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
151731000 cny
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
100473000 cny
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
177244000 cny
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
25698000 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
100473000 cny
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
177244000 cny
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
333000 cny
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
48000 usd
CY2020 us-gaap Interest Paid Net
InterestPaidNet
5171000 cny
CY2021 us-gaap Interest Paid Net
InterestPaidNet
2400000 cny
CY2022 us-gaap Interest Paid Net
InterestPaidNet
161000 cny
CY2022 us-gaap Interest Paid Net
InterestPaidNet
23000 usd
CY2020 us-gaap Income Taxes Paid
IncomeTaxesPaid
279000 cny
CY2021 us-gaap Income Taxes Paid
IncomeTaxesPaid
105000 cny
CY2022 us-gaap Income Taxes Paid
IncomeTaxesPaid
720000 cny
CY2022 us-gaap Income Taxes Paid
IncomeTaxesPaid
104000 usd
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
90115000 cny
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
168404000 cny
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
333000 cny
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
48000 usd
CY2020Q4 us-gaap Restricted Cash
RestrictedCash
10358000 cny
CY2021Q4 us-gaap Restricted Cash
RestrictedCash
8840000 cny
CY2020 metx Non Cash Total Cash Cash Equivalents And Restricted Cash Shown In The Statement Of Cash Flows
NonCashTotalCashCashEquivalentsAndRestrictedCashShownInTheStatementOfCashFlows
100473000 cny
CY2021 metx Non Cash Total Cash Cash Equivalents And Restricted Cash Shown In The Statement Of Cash Flows
NonCashTotalCashCashEquivalentsAndRestrictedCashShownInTheStatementOfCashFlows
177244000 cny
CY2022 metx Non Cash Total Cash Cash Equivalents And Restricted Cash Shown In The Statement Of Cash Flows
NonCashTotalCashCashEquivalentsAndRestrictedCashShownInTheStatementOfCashFlows
333000 cny
CY2022 metx Non Cash Total Cash Cash Equivalents And Restricted Cash Shown In The Statement Of Cash Flows
NonCashTotalCashCashEquivalentsAndRestrictedCashShownInTheStatementOfCashFlows
48000 usd
CY2020Q1 metx Merger Agreement Description
MergerAgreementDescription
the Company consummated its acquisition of Meten International and EdtechX, pursuant to the Merger Agreement, where the Company acquired 100% of the issued and outstanding ordinary shares of Meten International and EdtechX, i.e., 318,601,222 ordinary shares of Meten International and 1,971,505 ordinary shares of EdtechX for 1,613,054 and 65,717 ordinary shares of the Company, respectively (the “SPAC Transaction”).
CY2022 us-gaap Related Party Transaction Terms And Manner Of Settlement
RelatedPartyTransactionTermsAndMannerOfSettlement
The transaction is not a business combination because EdtechX was not a business. The transaction is accounted for as a reverse recapitalization, which is equivalent to the issuance of shares by Meten International for the net monetary assets of EdtechX, accompanied by a recapitalization. Meten International is determined as the predecessor and the historical financial statements of Meten International became the Company’s historical financial statements, with retrospective adjustments to give effect of the reverse recapitalization. The equity is restated using the exchange ratio of 0.1519 established in the reverse recapitalization transaction, which is 48,391,607 divided by 318,601,222, to reflect the equity structure of the Company. Loss (income) per share is retrospectively restated using the historical weighted-average number of ordinary shares outstanding multiplied by the exchange ratio. The share and per share data is retrospectively restated using the exchange ratio in the share-based compensation footnote, see Note 12. 
CY2022 metx Stock Issued During The Period New Issuance
StockIssuedDuringThePeriodNewIssuance
20000 usd
CY2022 metx Stock Issued During The Period Shares New Issues
StockIssuedDuringThePeriodSharesNewIssues
2000000 shares
CY2022 metx Merger Agreement Description
MergerAgreementDescription
In connection with merger transaction, on February 28, 2020, March 19, 2020 and March 26, 2020, three unrelated investors agreed to invest USD6,000, USD4,000 and USD6,000 to purchase shares of the Company. The financing of the USD12,000 was completed on March 30, 2020, and the USD4,000 financing was terminated on April 14, 2020 as the investor failed to pay the purchase price by the agreed deadline. 
CY2017Q4 us-gaap Stock Or Units Available For Distributions
StockOrUnitsAvailableForDistributions
30000000 shares
CY2017Q4 us-gaap Stock Issued1
StockIssued1
1000 cny
CY2022 us-gaap Distribution Made To Limited Partner Cash Distributions Paid
DistributionMadeToLimitedPartnerCashDistributionsPaid
148270000 cny
CY2022 us-gaap Use Of Estimates
UseOfEstimates
<table cellpadding="0" cellspacing="0" style="width: 100%; font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top"> <td style="width: 0.5in">(a)</td><td style="text-align: justify">Use of estimates</td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify">The preparation of the Company’s consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the balance sheet date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant items subject to such estimates and assumptions include, but are not limited to, estimate of standalone selling prices of each unit of accounting in multiple elements arrangements, estimate of breakage, the fair value of identifiable assets acquired, liabilities assumed and non-controlling interests in business combinations, the useful lives of long-lived assets including intangible assets, the fair value of the reporting unit for the goodwill impairment test, the allowance for doubtful accounts receivable and other receivables, the realization of deferred tax assets, the fair value of share-based compensation awards, lease liabilities, right-of-use assets and the recoverability of long-lived assets. Changes in facts and circumstances may result in revised estimates. Actual results could differ from those estimates, and as such, differences may be material to the consolidated financial statements.</p><p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"> </p>
CY2022Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
3845000 usd
CY2022Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
42716000 usd
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
8221000 usd
CY2022Q4 us-gaap Disposal Group Including Discontinued Operation Prepaid And Other Assets Current
DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent
47961000 usd
CY2022 metx Convenience Rate
ConvenienceRate
1000 usd
CY2022 metx Convenience Rate
ConvenienceRate
6897.2000 cny
CY2022 metx Miners
Miners
P5Y
CY2022Q4 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
5560000 usd
CY2022Q4 us-gaap Prepaid Taxes
PrepaidTaxes
14243000 usd
CY2022Q4 us-gaap Cash And Due From Banks
CashAndDueFromBanks
5376000 usd
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.10 pure
CY2022 metx Surplus Fund Percentage
SurplusFundPercentage
0.50 pure
CY2022Q4 us-gaap Restricted Cash
RestrictedCash
12100000 usd
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
16388000 usd
CY2022Q4 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
27564000 usd
CY2022Q4 us-gaap Property Plant And Equipment Owned Net
PropertyPlantAndEquipmentOwnedNet
11051000 usd
CY2022Q4 metx Intangible Assets
IntangibleAssets
11598000 usd
CY2022Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
42449000 usd
CY2022Q4 us-gaap Goodwill
Goodwill
192962000 usd
CY2022Q4 metx Biusiness Combination Operating Lease Rightofuse
BiusinessCombinationOperatingLeaseRightofuse
43353000 usd
CY2022Q4 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Other Noncurrent Assets
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets
16050000 usd
metx Accounts Payable
AccountsPayable
15019000 usd
metx Deferred Revenue Current1
DeferredRevenueCurrent1
130704000 usd
metx Salary And Welfare Payable
SalaryAndWelfarePayable
9408000 usd
CY2022Q4 metx Financial Liabilities From Contracts With Customers
FinancialLiabilitiesFromContractsWithCustomers
-267796000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-49525000 usd
metx Income Taxes Payable
IncomeTaxesPayable
-135000 usd
CY2022Q4 metx Business Combination Operating Lease Liabilities
BusinessCombinationOperatingLeaseLiabilities
-17902000 usd
us-gaap Increase Decrease In Due From Related Parties
IncreaseDecreaseInDueFromRelatedParties
-22232000 usd
CY2022Q4 metx Deferred Revenue Noncurrent1
DeferredRevenueNoncurrent1
-30852000 usd
CY2022Q4 metx Deferred Tax Liabilities1
DeferredTaxLiabilities1
-858000 usd
CY2022Q4 us-gaap Liability For Uncertain Tax Positions Noncurrent
LiabilityForUncertainTaxPositionsNoncurrent
34265000 usd
CY2022Q4 metx Lease Liabilities
LeaseLiabilities
-15504000 usd
CY2022Q4 us-gaap Long Term Debt
LongTermDebt
92763000 usd
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
18035000 usd
CY2022Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
74728000 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
74728000 usd
CY2021Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
5323000 usd
CY2021Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
44291000 usd
CY2021Q4 us-gaap Other Assets Current
OtherAssetsCurrent
32241000 usd
CY2021Q4 us-gaap Disposal Group Including Discontinued Operation Prepaid And Other Assets Current
DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent
38600000 usd
CY2021Q4 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
7265000 usd
CY2021Q4 us-gaap Prepaid Taxes
PrepaidTaxes
14479000 usd
CY2021Q4 metx Current Assets For Discontinued Operations Total
CurrentAssetsForDiscontinuedOperationsTotal
142199000 usd
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
11149000 usd
CY2021Q4 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
24403000 usd
CY2021Q4 us-gaap Property Plant And Equipment Owned Net
PropertyPlantAndEquipmentOwnedNet
85803000 usd
CY2021Q4 metx Intangible Assets
IntangibleAssets
14675000 usd
CY2021Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
25991000 usd
CY2021Q4 us-gaap Goodwill
Goodwill
192962000 usd
CY2021Q4 metx Biusiness Combination Operating Lease Rightofuse
BiusinessCombinationOperatingLeaseRightofuse
105551000 usd
CY2021Q4 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Other Noncurrent Assets
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets
26254000 usd
CY2021Q4 us-gaap Other Inventory Net Of Reserves
OtherInventoryNetOfReserves
486788000 usd
CY2021 metx Accounts Payable
AccountsPayable
-16164000 usd
CY2021Q4 us-gaap Short Term Bank Loans And Notes Payable
ShortTermBankLoansAndNotesPayable
6000000 usd
CY2021 metx Deferred Revenue Current1
DeferredRevenueCurrent1
-213006000 usd
CY2021 metx Salary And Welfare Payable
SalaryAndWelfarePayable
-27404000 usd
CY2021Q4 metx Financial Liabilities From Contracts With Customers
FinancialLiabilitiesFromContractsWithCustomers
337932000 usd
CY2021 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
36575000 usd
CY2021 metx Income Taxes Payable
IncomeTaxesPayable
195000 usd
CY2021Q4 metx Business Combination Operating Lease Liabilities
BusinessCombinationOperatingLeaseLiabilities
35817000 usd
CY2021 us-gaap Increase Decrease In Due From Related Parties
IncreaseDecreaseInDueFromRelatedParties
11256000 usd
CY2021Q4 us-gaap Other Employee Related Liabilities Current
OtherEmployeeRelatedLiabilitiesCurrent
684349000 usd
CY2021Q4 metx Deferred Revenue Noncurrent1
DeferredRevenueNoncurrent1
35546000 usd
CY2021Q4 metx Deferred Tax Liabilities1
DeferredTaxLiabilities1
4433000 usd
CY2021Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
34137000 usd
CY2021Q4 metx Lease Liabilities
LeaseLiabilities
59824000 usd
CY2021Q4 us-gaap Other Employee Related Liabilities Current And Noncurrent
OtherEmployeeRelatedLiabilitiesCurrentAndNoncurrent
133940000 usd
CY2022Q4 us-gaap Accounts Receivable Gross
AccountsReceivableGross
61396000 cny
CY2022Q4 us-gaap Disposal Group Including Discontinued Operation Accounts Notes And Loans Receivable Net
DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet
61396000 cny
CY2022Q4 us-gaap Debt Instrument Maturity Date
DebtInstrumentMaturityDate
2023-10-01
CY2022Q4 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
1000000 usd
CY2021Q4 us-gaap Property Plant And Equipment Other
PropertyPlantAndEquipmentOther
70031000 cny
CY2022Q4 us-gaap Property Plant And Equipment Other
PropertyPlantAndEquipmentOther
22322000 cny
CY2021Q4 us-gaap Other Interest Earning Assets
OtherInterestEarningAssets
9104000 cny
CY2022Q4 us-gaap Other Interest Earning Assets
OtherInterestEarningAssets
12260000 cny
CY2021Q4 us-gaap Other Assets Miscellaneous
OtherAssetsMiscellaneous
79135000 cny
CY2022Q4 us-gaap Other Assets Miscellaneous
OtherAssetsMiscellaneous
34582000 cny
CY2022Q4 us-gaap Servicing Asset
ServicingAsset
626000 cny
CY2022Q4 us-gaap Guaranty Assets
GuarantyAssets
626000 cny
CY2022 metx Receipt Of Bitcoins From Mining Services
ReceiptOfBitcoinsFromMiningServices
16496000 cny
CY2022 metx Receipt Of Bitcoins From Hash Power Rental
ReceiptOfBitcoinsFromHashPowerRental
903000 cny
CY2022 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-16751000 cny
CY2022 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
22000 cny
CY2022Q4 us-gaap Derivative Fair Value Of Derivative Liability
DerivativeFairValueOfDerivativeLiability
626000 cny
CY2022 us-gaap Deferred Revenue Revenue Recognized1
DeferredRevenueRevenueRecognized1
22000 cny
CY2022Q4 us-gaap Investment Interest Rate
InvestmentInterestRate
0.02 pure
CY2021Q4 us-gaap Derivative Fixed Interest Rate
DerivativeFixedInterestRate
0.21 pure
CY2022Q4 us-gaap Common Stock Dividends Shares
CommonStockDividendsShares
3532841 shares
CY2022Q4 us-gaap Business Acquisition Pro Forma Income Loss From Continuing Operations Before Changes In Accounting And Extraordinary Items Net Of Tax Per Share Basic
BusinessAcquisitionProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTaxPerShareBasic
0.003
CY2022Q4 us-gaap Payments Of Ordinary Dividends
PaymentsOfOrdinaryDividends
7120478000 cny
CY2022Q4 us-gaap Derivative Fixed Interest Rate
DerivativeFixedInterestRate
0.243 pure
CY2022 us-gaap Equity Method Investment Deferred Gain On Sale
EquityMethodInvestmentDeferredGainOnSale
83000000 cny
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
104971000 cny
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
12528000 cny
CY2022Q4 us-gaap Property Plant And Equipment Other Net
PropertyPlantAndEquipmentOtherNet
92443000 cny
CY2022 us-gaap Depreciation
Depreciation
12528000 cny
CY2022 metx Profits Tax Rate Description
ProfitsTaxRateDescription
A Two-tiered Profits Tax rates regime was introduced since year 2018 where the first HK$2,000 of assessable profits earned by a company will be taxed at half the current tax rate (8.25%) whilst the remaining profits will continue to be taxed at 16.5%.
CY2022Q4 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
6897200 cny
CY2022Q4 us-gaap Derivative Fixed Interest Rate
DerivativeFixedInterestRate
0.12 pure
CY2022Q4 metx Loan Guarantee Unit
LoanGuaranteeUnit
147 pure
CY2020 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-11792000 cny
CY2021 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-12102000 cny
CY2022 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
6670000 cny
CY2020 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
61846 shares
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
454495 shares
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13655571 shares
CY2020 metx Effect Of Dilutive Securities
EffectOfDilutiveSecurities
11312 shares
CY2021 metx Effect Of Dilutive Securities
EffectOfDilutiveSecurities
-53160 shares
CY2020 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
73158 shares
CY2021 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
401335 shares
CY2022 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
13655571 shares
CY2020 metx Losses Per Share From Continuing Operations Basicin Dollars Per Share
LossesPerShareFromContinuingOperationsBasicinDollarsPerShare
-190.67
CY2021 metx Losses Per Share From Continuing Operations Basicin Dollars Per Share
LossesPerShareFromContinuingOperationsBasicinDollarsPerShare
-26.63
CY2022 metx Losses Per Share From Continuing Operations Basicin Dollars Per Share
LossesPerShareFromContinuingOperationsBasicinDollarsPerShare
0.49
CY2020 metx Losses Per Share From Continuing Operationsdiluted
LossesPerShareFromContinuingOperationsdiluted
-161.19
CY2021 metx Losses Per Share From Continuing Operationsdiluted
LossesPerShareFromContinuingOperationsdiluted
-30.15
CY2022 metx Losses Per Share From Continuing Operationsdiluted
LossesPerShareFromContinuingOperationsdiluted
0.49
CY2020 metx Losses Per Share From Discontinued Operations Basicin Dollars Per Share
LossesPerShareFromDiscontinuedOperationsBasicinDollarsPerShare
-399193
CY2021 metx Losses Per Share From Discontinued Operations Basicin Dollars Per Share
LossesPerShareFromDiscontinuedOperationsBasicinDollarsPerShare
-372197
CY2022 metx Losses Per Share From Discontinued Operations Basicin Dollars Per Share
LossesPerShareFromDiscontinuedOperationsBasicinDollarsPerShare
46343
CY2020 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
61846 shares
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
454495 shares
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13655571 shares
CY2020 metx Effect Of Dilutive Securities
EffectOfDilutiveSecurities
11312 shares
CY2021 metx Effect Of Dilutive Securities
EffectOfDilutiveSecurities
-53160 shares
CY2020 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
73158 shares
CY2021 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
401335 shares
CY2022 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
13655571 shares
CY2020 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-6454.62
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-818.92
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
3.39
CY2020 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-5456.6
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-927.4
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
3.39
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
2178528 shares
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P5Y
CY2017 metx Subscription Price
SubscriptionPrice
1
CY2019Q4 metx Share Based Compensation Description
ShareBasedCompensationDescription
On December 14, 2019 (“Vesting Commencement Date”), the Company further granted 8,357,311 share units to employees which vested one week after the Vesting Commencement Date at weighted average subscription price of USD0.0055 per unit.
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1854193 shares
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
24.16
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
72865 shares
CY2018 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
38.52
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1781328 shares
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
23.47
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1269373 shares
CY2019 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
70.32
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3050701 shares
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
43.52
CY2020Q1 us-gaap Excess Stock Shares Issued
ExcessStockSharesIssued
3050701 shares
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Percentage Of Outstanding Stock Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum
0.01 pure
CY2018 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
7648000 cny
CY2019 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
96661000 cny
CY2020 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
27664000 cny
CY2020Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
6351000 cny
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P1Y6M
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Award Vesting Rights Percentage
SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
0.15 pure
CY2021 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
11178000 cny
CY2019Q3 us-gaap Shares Issued
SharesIssued
500000000 shares
CY2019Q3 us-gaap Share Price
SharePrice
0.0001
CY2018Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
380000 hkd
CY2018Q3 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
38000000 shares
CY2018Q3 us-gaap Share Price
SharePrice
0.01
CY2018Q4 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
500000000 shares
CY2018Q4 us-gaap Shares Issued
SharesIssued
318601222 shares
CY2018Q4 us-gaap Share Price
SharePrice
0.0001
CY2018Q4 us-gaap Stock Repurchase Program Remaining Number Of Shares Authorized To Be Repurchased
StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased
47035 shares
CY2018Q4 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
0.01
CY2018Q4 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
0.01
CY2020Q1 us-gaap Conversion Of Stock Shares Issued1
ConversionOfStockSharesIssued1
48391607 shares
CY2020Q1 us-gaap Capital Units Total Cost To Investors
CapitalUnitsTotalCostToInvestors
6000 usd
CY2020Q1 us-gaap Capital Units Total Cost To Investors
CapitalUnitsTotalCostToInvestors
4000 usd
CY2020Q1 us-gaap Capital Units Total Cost To Investors
CapitalUnitsTotalCostToInvestors
6000 usd
CY2020Q1 us-gaap Capital Units Deductions From Total Cost To Investors
CapitalUnitsDeductionsFromTotalCostToInvestors
6000 usd
CY2020Q2 us-gaap Capital Units Deductions From Total Cost To Investors
CapitalUnitsDeductionsFromTotalCostToInvestors
4000 usd
CY2020Q2 us-gaap Shares Issued
SharesIssued
3050701 shares
CY2020Q2 us-gaap Shares Outstanding
SharesOutstanding
3050701 shares
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Percentage Of Outstanding Stock Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum
0.01 pure
CY2022Q4 us-gaap Shares Issued
SharesIssued
531005 shares
CY2022 metx Additional Share Based Compensation Arrangement By Share Based Payment Award Percentage Of Outstanding Stock Maximum
AdditionalShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum
0.01 pure
CY2021Q1 us-gaap Shares Issued
SharesIssued
1327514 shares
CY2021Q2 us-gaap Shares Issued
SharesIssued
40000000 shares
CY2021Q2 metx Ordinary Share Par Value
OrdinaryShareParValue
0.0001
CY2021Q2 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
1
CY2021Q3 us-gaap Shares Issued
SharesIssued
22500000 shares
CY2021Q3 metx Ordinary Share Par Value
OrdinaryShareParValue
0.0001
CY2021Q3 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
0.3
CY2021Q4 us-gaap Shares Issued
SharesIssued
33333334 shares
CY2021Q4 metx Ordinary Share Par Value
OrdinaryShareParValue
0.0001
CY2021Q4 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
0.6
CY2022Q2 metx Ordinary Share Par Value
OrdinaryShareParValue
0.003
CY2022Q3 us-gaap Shares Issued
SharesIssued
1470475 shares
CY2022Q3 metx Ordinary Share Par Value
OrdinaryShareParValue
0.0001
CY2022Q3 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
0.3
CY2022Q4 us-gaap Shares Issued
SharesIssued
3532841 shares
CY2022Q4 metx Ordinary Share Par Value
OrdinaryShareParValue
0.003
CY2022Q4 us-gaap Common Unit Issuance Value
CommonUnitIssuanceValue
7120478 cny
CY2022Q4 metx Equity Methods Investment Ownership Percentage
EquityMethodsInvestmentOwnershipPercentage
0.033 pure
CY2021Q4 us-gaap Excess Stock Shares Issued
ExcessStockSharesIssued
11371444 shares
CY2021Q4 us-gaap Excess Stock Shares Outstanding
ExcessStockSharesOutstanding
11371444 shares
CY2022Q4 us-gaap Excess Stock Shares Issued
ExcessStockSharesIssued
20880171 shares
CY2022Q4 us-gaap Excess Stock Shares Outstanding
ExcessStockSharesOutstanding
20880171 shares
CY2020Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
12705000 shares
CY2021Q1 us-gaap Warrant Exercise Price Decrease
WarrantExercisePriceDecrease
1.4
CY2022 us-gaap Class Of Warrant Or Right Reason For Issuing To Nonemployees
ClassOfWarrantOrRightReasonForIssuingToNonemployees
The Company raised $6,192,286.80 in gross proceeds from the cash exercise of 4,423,062 warrants of the Company as part of the tender offer. In addition, 2,629,812 warrants to purchase ordinary shares of the Company were validly tendered for cashless exercise, resulting in the issuance of 1,364,512 ordinary shares of the Company. The Company offered its existing loyal warrant holders the opportunity to exercise their warrants at $1.40 from the initial warrant exercise price at $11.50. Approximately 55.5% of the Company’s outstanding warrants were exercised in the tender offer. 
CY2022 metx Agent Fees
AgentFees
5730000 usd
CY2021Q1 metx Warrants To Purchase Ordinary Shares
WarrantsToPurchaseOrdinaryShares
336001 shares
CY2021Q1 us-gaap Shares Issued
SharesIssued
336001 shares
CY2021Q1 metx Warrant Exercise Price
WarrantExercisePrice
2.5
CY2021Q2 metx Warrant Exercise Price
WarrantExercisePrice
1
CY2021Q3 us-gaap Class Of Warrant Or Right Reason For Issuing To Nonemployees
ClassOfWarrantOrRightReasonForIssuingToNonemployees
the Company offered 22,500,000 ordinary shares, par value US$0.0001 per share at a purchase price of US$0.30 per share. The Company also offered 177,500,000 pre-funded warrants to purchase 177,500,000 ordinary shares, exercisable at an exercise price of $0.0001 per share (the “Pre-funded Warrants”, each a “Pre-funded Warrant”), to those purchasers whose purchase of ordinary shares in the offering would otherwise result in the purchaser, together with its affiliates and certain related parties, beneficially owning more than 4.99% (or, at the election of the holder, 9.99%) of the Company’s outstanding ordinary shares immediately following the consummation of the offering. The purchase price of each Pre-funded Warrant is $0.2999, which equals the price per ordinary share being sold to the public in that offering, minus $0.0001. The Pre-funded Warrants became immediately exercisable upon issuance and may be exercised at any time until all of the Pre-funded Warrants are exercised in full
CY2022 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
the Company became exercisable for 1/30 ordinary share of the Company, and the exercise price of Company’s outstanding warrants was increased to US$9.00, adjusted from $0.30 prior to the Reverse Split and representing the temporarily reduced price based on the Company’s Tender Offer Statement on Schedule TO, as amended and supplemented, originally filed by the Company with the U.S. Securities and Exchange Commission on December 7, 2020 (the “Tender Offer”). Based on the terms of the Tender Offer, following the date on which the closing price of the Company’s ordinary shares has been equal to or greater than $90.00 per share for at least twenty (20) trading days during the preceding thirty (30) trading day period, the exercise price of the Company’s outstanding warrants would be increased to US$345.00.
CY2022Q3 metx Ordinary Shares Description
OrdinarySharesDescription
the Company offered 22,899,047 ordinary shares, par value US$0.003 per share, consisting of (a) 1,470,475 ordinary shares issuable upon the exercise of pre-funded warrants (the “Pre-Funded Warrants”) and (b) 21,428,572 ordinary shares issuable upon the exercise of investor warrants (the “Investor Warrants”). Each Pre-Funded Warrant is exercisable for $0.001 per ordinary share and may be exercised at any time until all the Pre-Funded Warrants are exercised in full; and each Investor Warrant has an exercise price of $0.70 per share, is exercisable on or after August 8, 2022 and will expire on August 9, 2027.
CY2022Q3 us-gaap Warrant Exercise Price Decrease
WarrantExercisePriceDecrease
0.7
CY2022Q3 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
345 usd
CY2022 us-gaap Related Party Transaction Description Of Transaction
RelatedPartyTransactionDescriptionOfTransaction
An associate of the Company
CY2020Q4 us-gaap Due From Other Related Parties
DueFromOtherRelatedParties
30893000 cny
CY2021Q4 us-gaap Due From Other Related Parties
DueFromOtherRelatedParties
54874000 cny
CY2022Q4 us-gaap Due From Other Related Parties
DueFromOtherRelatedParties
26218000 cny
CY2021 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
55265000 cny
CY2022 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
10242000 cny
CY2021Q4 us-gaap Due To Related Parties Current And Noncurrent
DueToRelatedPartiesCurrentAndNoncurrent
30502000 cny
CY2022Q4 us-gaap Due To Related Parties Current And Noncurrent
DueToRelatedPartiesCurrentAndNoncurrent
46478000 cny
CY2022 dei Document Accounting Standard
DocumentAccountingStandard
U.S. GAAP
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
cny
CY2021Q4 us-gaap Other Assets
OtherAssets
cny
CY2022Q4 us-gaap Assets Of Disposal Group Including Discontinued Operation Current
AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
cny
CY2022Q4 us-gaap Assets Of Disposal Group Including Discontinued Operation Current
AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
usd
CY2022Q4 us-gaap Restricted Cash
RestrictedCash
cny
CY2022Q4 us-gaap Restricted Cash
RestrictedCash
usd
CY2021Q4 us-gaap Equity Method Investments
EquityMethodInvestments
cny
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
cny
CY2022Q4 us-gaap Disposal Group Including Discontinued Operation Assets Noncurrent
DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent
cny
CY2022Q4 us-gaap Disposal Group Including Discontinued Operation Assets Noncurrent
DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent
usd
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
cny
CY2021Q4 us-gaap Other Short Term Borrowings
OtherShortTermBorrowings
cny
CY2022Q4 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Current
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
cny
CY2022Q4 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Current
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
usd
CY2022Q4 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Noncurrent
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent
cny
CY2022Q4 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Noncurrent
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent
usd
CY2022Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
cny
CY2022Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
usd
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.003
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.003
CY2022Q4 us-gaap Minority Interest
MinorityInterest
cny
CY2022Q4 us-gaap Minority Interest
MinorityInterest
usd
CY2020 us-gaap Revenues
Revenues
cny
CY2021 us-gaap Revenues
Revenues
cny
CY2020 us-gaap Cost Of Revenue
CostOfRevenue
cny
CY2021 us-gaap Cost Of Revenue
CostOfRevenue
cny
CY2020 us-gaap Gross Profit
GrossProfit
cny
CY2021 us-gaap Gross Profit
GrossProfit
cny
CY2020 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
cny
CY2021 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
cny
CY2022 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
cny
CY2022 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
usd
CY2020 us-gaap Interest Expense
InterestExpense
cny
CY2021 us-gaap Interest Expense
InterestExpense
cny
CY2020 us-gaap Noncontrolling Interest In Net Income Loss Other Noncontrolling Interests Redeemable
NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable
cny
CY2021 us-gaap Noncontrolling Interest In Net Income Loss Other Noncontrolling Interests Redeemable
NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable
cny
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
cny
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
cny
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
cny
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2020 metx Gains On Disposal Of Subsidiaries
GainsOnDisposalOfSubsidiaries
cny
CY2021 metx Gains On Disposal Of Subsidiaries
GainsOnDisposalOfSubsidiaries
cny
CY2020 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-19067
CY2021 metx Realized Gain On Exchange Of Digital Assets
RealizedGainOnExchangeOfDigitalAssets
cny
CY2022 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
cny
CY2022 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
usd
CY2021 metx Impairment Losses On Cryptocurrency Assets
ImpairmentLossesOnCryptocurrencyAssets
cny
CY2022 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
usd
CY2021 metx Increasedecreasecryptocurrencyassets
Increasedecreasecryptocurrencyassets
cny
CY2021 us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
cny
CY2022 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
cny
CY2022 metx Proceeds From Maturities Of Shortterm Investment
ProceedsFromMaturitiesOfShorttermInvestment
cny
CY2022Q4 us-gaap Restricted Cash
RestrictedCash
usd
CY2022Q4 us-gaap Asset Acquisition Contingent Consideration Liability
AssetAcquisitionContingentConsiderationLiability
usd
CY2021Q4 us-gaap Assets Of Disposal Group Including Discontinued Operation
AssetsOfDisposalGroupIncludingDiscontinuedOperation
usd
CY2021Q4 us-gaap Accounts Receivable Gross
AccountsReceivableGross
cny
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
cny
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
cny
CY2021Q4 us-gaap Disposal Group Including Discontinued Operation Accounts Notes And Loans Receivable Net
DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet
cny
CY2021Q4 us-gaap Servicing Asset
ServicingAsset
cny
CY2021Q4 us-gaap Guaranty Assets
GuarantyAssets
cny
CY2020Q4 us-gaap Derivative Fair Value Of Derivative Liability
DerivativeFairValueOfDerivativeLiability
cny
CY2021Q4 us-gaap Derivative Fair Value Of Derivative Liability
DerivativeFairValueOfDerivativeLiability
cny
CY2021 metx Receipt Of Bitcoins From Mining Services
ReceiptOfBitcoinsFromMiningServices
cny
CY2021 metx Receipt Of Bitcoins From Hash Power Rental
ReceiptOfBitcoinsFromHashPowerRental
cny
CY2021 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
cny
CY2021 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
cny
CY2021Q4 us-gaap Derivative Fair Value Of Derivative Liability
DerivativeFairValueOfDerivativeLiability
cny
CY2021 us-gaap Deferred Revenue Revenue Recognized1
DeferredRevenueRevenueRecognized1
usd
CY2020 us-gaap Deferred Revenue Revenue Recognized1
DeferredRevenueRevenueRecognized1
usd
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
cny
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
cny
CY2021Q4 us-gaap Property Plant And Equipment Other Net
PropertyPlantAndEquipmentOtherNet
cny
CY2020 us-gaap Depreciation
Depreciation
cny
CY2021 us-gaap Depreciation
Depreciation
cny
CY2020 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-11792000 cny
CY2021 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-12102000 cny
CY2022 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
6670000 cny
CY2022 metx Effect Of Dilutive Securities
EffectOfDilutiveSecurities
shares
CY2022 metx Effect Of Dilutive Securities
EffectOfDilutiveSecurities
shares
CY2022 dei Amendment Flag
AmendmentFlag
false
CY2022 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2022 dei Entity Central Index Key
EntityCentralIndexKey
0001796514

Files In Submission

Name View Source Status
FilingSummary.xml Edgar Link unprocessable
metx-20221231_pre.xml Edgar Link unprocessable
metx-20221231_cal.xml Edgar Link unprocessable
metx-20221231_def.xml Edgar Link unprocessable
metx-20221231_lab.xml Edgar Link unprocessable
0001213900-23-020144-index-headers.html Edgar Link pending
0001213900-23-020144-index.html Edgar Link pending
0001213900-23-020144.txt Edgar Link pending
0001213900-23-020144-xbrl.zip Edgar Link pending
ex15-1_001.jpg Edgar Link pending
ex15-1_002.jpg Edgar Link pending
ex15-1_003.jpg Edgar Link pending
ex4-10_001.jpg Edgar Link pending
ex4-12_001.jpg Edgar Link pending
ex4-12_002.jpg Edgar Link pending
ex4-12_003.jpg Edgar Link pending
ex4-12_004.jpg Edgar Link pending
ex4-12_005.jpg Edgar Link pending
ex4-12_006.jpg Edgar Link pending
ex4-12_007.jpg Edgar Link pending
ex4-12_008.jpg Edgar Link pending
ex4-12_009.jpg Edgar Link pending
ex4-12_010.jpg Edgar Link pending
ex4-12_011.jpg Edgar Link pending
ex4-12_012.jpg Edgar Link pending
ex4-12_013.jpg Edgar Link pending
ex4-12_014.jpg Edgar Link pending
ex4-12_015.jpg Edgar Link pending
ex4-12_016.jpg Edgar Link pending
f20f2022ex12-1_metenholding.htm Edgar Link pending
f20f2022ex12-2_metenholding.htm Edgar Link pending
f20f2022ex13-1_metenholding.htm Edgar Link pending
f20f2022ex13-2_metenholding.htm Edgar Link pending
f20f2022ex15-1_metenholding.htm Edgar Link pending
f20f2022ex4-10_metenholding.htm Edgar Link pending
f20f2022ex4-11_metenholding.htm Edgar Link pending
f20f2022ex4-12_metenholding.htm Edgar Link pending
f20f2022ex8-1_metenholding.htm Edgar Link pending
f20f2022_metenholding.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
image_001.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
metx-20221231.xsd Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
f20f2022_metenholding_htm.xml Edgar Link completed
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending